| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ionis Pharmaceuticals, Inc. (IONS) has 21 insiders with recent SEC Form 4 filings, including 0 buys and 4 sells. IONS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 260.3K | $19.78M | - | |
| Dir | 164.0K | $12.46M | -8,000 | |
| VP | 100.3K | $7.62M | - | |
| VP | 83.3K | $6.33M | -60,846 | |
| CFO | 82.7K | $6.28M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 1, 2019 | Bennett C Frank64 | SVP, Antisense Research | Sale+OE | 9,013 | $58.29 | $525,367.77 | -26.9% | |
| Jan 3, 2019 | O'Neil Patrick R.57 | SVP Legal &General Counsel | Sale+OE | 4,400 | $54.80 | $241,120.00 | -13.1% | |
| Jan 2, 2019 | Monia Brett P60 | Chief Operating Officer | Sell | 214 | $53.50 | $11,449.00 | -1.3% |